Terug
Dagbereik
€ 3,27
€ 3,40
52-Weeksbereik
€ 1,15
€ 6,75
Volume
4.976.975
50D / 200D Gem.
€ 3,80
/
€ 4,04
Vorige Slotkoers
€ 3,39
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,0 | 0,4 |
| P/B | 2,9 | 2,9 |
| ROE % | -390,4 | 3,7 |
| Net Margin % | -16142,0 | 3,9 |
| Rev Growth 5Y % | -33,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 11,75
+247.6%
Low: € 10,00
High: € 14,00
Forward WPA
-€ 0,48
Omzet Sch.
470000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,23
€ 0,23 – € 0,23
|
440 M | 4 |
| FY2029 |
-€ 0,26
-€ 0,26 – -€ 0,26
|
190 M | 4 |
| FY2028 |
-€ 0,47
-€ 0,77 – -€ 0,29
|
20 M | 10 |
Belangrijkste Punten
Revenue declined -33,07% annually over 5 years
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -103,58M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 1260,67%
Groei
Revenue Growth (5Y)
-33,07%
Revenue (1Y)1227,60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-390,36%
ROIC-38,20%
Net Margin-16142,02%
Op. Margin-2789,46%
Veiligheid
Debt / Equity
0,01
Current Ratio11,74
Interest Coverage-98,16
Waardering
P/E Ratio
-0,97
P/B Ratio2,87
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1227,60% | Revenue Growth (3Y) | 260,86% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -33,07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,09M | Net Income (TTM) | -660,05M |
| ROE | -390,36% | ROA | -212,55% |
| Gross Margin | 75,25% | Operating Margin | -2789,46% |
| Net Margin | -16142,02% | Free Cash Flow (TTM) | -103,58M |
| ROIC | -38,20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 11,74 |
| Interest Coverage | -98,16 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -0,97 | P/B Ratio | 2,87 |
| P/S Ratio | 155,92 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 637,55M | Enterprise Value | 554,32M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,09M | 308.000,0 | 314.000,0 | 233.000,0 | 20,38M |
| Net Income | -660,05M | -149,27M | -40,22M | -152,39M | -167,81M |
| EPS (Diluted) | -2,91 | -0,93 | -0,25 | -0,91 | -0,83 |
| Gross Profit | 3,08M | 308.000,0 | 314.000,0 | 233.000,0 | 20,38M |
| Operating Income | -114,06M | -102,69M | -125,47M | -144,79M | -135,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 310,54M | 159,39M | 293,48M | 305,44M | 414,17M |
| Total Liabilities | 88,54M | 42,83M | 49,16M | 39,68M | 28,21M |
| Shareholders' Equity | 221,87M | 116,30M | 242,96M | 260,74M | 376,91M |
| Total Debt | 2,07M | 24,71M | 19,14M | 15,34M | 743.000,0 |
| Cash & Equivalents | 85,30M | 17,51M | 45,03M | 190,61M | 362,27M |
| Current Assets | 275,68M | 80,13M | 185,59M | 287,15M | 375,08M |
| Current Liabilities | 23,48M | 24,95M | 20,12M | 19,90M | 20,94M |